国产及进口肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效比较

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (3): 296-299.

国产及进口肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效比较

冯思国¹, 钟晓蓉²

¹浙江省苍南县第二人民医院儿科,苍南 325802,浙江;
²浙江省松阳县中医院儿科,松阳 323400,浙江

收稿日期:2011-01-26 修回日期:2011-02-23 出版日期:2011-03-26 发布日期:2011-05-18
作者简介:冯思国,男,主治医师,研究方向:临床儿科。Tel: 18857793213 E-mail: fengsgcn@163.com

Comparison on curative effects between domestic and imported pulmonary surfactant on neonatal respiratory distress syndrome

FENG Si-guo¹, ZHONG Xiao-rong²

¹Department of Pediatrics, the Second People's Hospital of Cangnan County, Cangnan 325802,Zhejiang, China;
²Department of Pediatrics, Songyang County Traditional Medicine of Chinese Hospital , Songyang 323400,Zhejiang,China

Received:2011-01-26 Revised:2011-02-23 Online:2011-03-26 Published:2011-05-18

摘要/Abstract

摘要： 目的: 观察国产及进口肺表面活性物质(pulmonary surfactant,PS)治疗新生儿呼吸窘迫综合征(neonatal respiratory distress syndrome, NRDS)的疗效。方法: 将54例NRDS患儿随机分为珂立苏组(28例)和固尔舒组 (26例),两组在常规治疗的同时,分别给予珂立苏与固尔舒气管内滴注观察两组的疗效。结果: 用药前两组患儿均有严重低氧血症,用药后 30 min 两组患儿动脉-肺泡氧分压比值(a/APO₂)和 PaO₂/FiO₂ 明显上升,换气功能改善,用药 72 min 后呼吸机参数下调。两种药物都可明显缩短机械通气的时间。结论: 国产及进口PS治疗NRDS疗效相当,无明显差异。

关键词: 新生儿, 呼吸窘迫综合征, 肺表面活性物质

Abstract: AIM: To compare the curative effects between domestic and imported pulmonary surfactant on neonatal respiratory distress syndrome (NRDS).METHODS: 54 neonates with NRDS were randomly divided into Calsurf group (domestic pulmonary surfactant, 28 cases) and Curosurf group (imported pulmonary surfactant 26 cases) .At the basic of conventional therapy, the two groups received domestic or imported pulmonary surfactant with single dose by intratracheal administration, respectively. The curative effects and adverse reaction were observed.RESULTS: Before using these drugs, the patients in two groups were all with hypoxemia, the artery - alveolar pressure ratio (a/APO₂) and PaO₂/FiO₂ were increased significantly after 30 minutes. The gas exchange function was improved; the breathing machine parameters were lowered 72 minutes later. Two drugs could significantly reduce mechanical ventilation of time and improve the success rate of treatment.CONCLUSION: Both the domestic and imported pulmonary surfactant have the same good curative effects and safety on neonatal NRDS.

Key words: Neonatal, Respiratory distress syndrome, Pulmonary surfactant

中图分类号:

R725

冯思国, 钟晓蓉. 国产及进口肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效比较[J]. 中国临床药理学与治疗学, 2011, 16(3): 296-299.

FENG Si-guo, ZHONG Xiao-rong. Comparison on curative effects between domestic and imported pulmonary surfactant on neonatal respiratory distress syndrome[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 296-299.

[1]	姜莉，李宇宁，庞立宏，张兴道，王芳. N-乙酰半胱氨酸联合肺表面活性物质对新生儿重症胎粪吸入综合征的疗效及其对胎儿炎症因子及氧合功能的影响[J]. 中国临床药理学与治疗学, 2020, 25(1): 81-86.
[2]	刘焕淼，陈焯辉，吴迪，黄雪婷，万齐全. 胰岛素通过PI3K/AKT及PI3K/ERK通路减轻脂多糖对钠泵α1亚基的抑制[J]. 中国临床药理学与治疗学, 2019, 24(8): 896-902.
[3]	华旭丹，解红艺，余淑芳. C反应蛋白和降钙素原指导高危新生儿预防性应用抗生素的效果、安全性和经济性分析[J]. 中国临床药理学与治疗学, 2019, 24(5): 561-566.
[4]	蒋豪明，陈翔，李珍，顾承萍. 单唾液酸四己糖神经节苷脂联合鼠神经生长因子对新生儿缺氧缺血性脑病的临床研究[J]. 中国临床药理学与治疗学, 2019, 24(3): 301-306.
[5]	李勇裴，朱云霞，黄婷. 中药水疗联合茵栀黄口服液对新生儿黄疸的临床疗效[J]. 中国临床药理学与治疗学, 2018, 23(9): 1047-1051.
[6]	余金晶，张彦萍，潘家华. 抚触联合益生菌早期干预对晚期早产儿黄疸的影响[J]. 中国临床药理学与治疗学, 2018, 23(6): 678-681.
[7]	方声，王丽珍. 脑苷肌肽对缺氧缺血性脑病血清胰岛素样生长因子1及治疗预后的影响[J]. 中国临床药理学与治疗学, 2017, 22(1): 72-76.
[8]	蒋丽芳，杨莲芳，朱璐卡. 肺表面活性物质联合双相呼吸道正压通气治疗新生儿呼吸窘迫综合征的临床研究[J]. 中国临床药理学与治疗学, 2016, 21(9): 1042-1045.
[9]	包长顺，包文朝. 纳美芬对新生儿窒息后血浆β-内啡肽表达的影响[J]. 中国临床药理学与治疗学, 2016, 21(5): 558-561.
[10]	潘荣华, 张士发, 邰海服, 胡芳, 陈爱斌, 茅双根. 肺表面活性物质治疗足月新生儿肺出血的临床研究[J]. 中国临床药理学与治疗学, 2014, 19(4): 454-458.
[11]	阮冠宇, 许秋星, 蔡慧雅, 邓婕, 史道华. 二甲双胍与胰岛素对母亲妊娠期糖尿病新生儿安全性的系统评价[J]. 中国临床药理学与治疗学, 2014, 19(10): 1139-1143.
[12]	金立达, 王良荣, 熊响清, 林丽娜, 单鸳露, 周俊辉. 环氧合酶-2抑制剂对大鼠机械通气所致肺损伤的影响[J]. 中国临床药理学与治疗学, 2012, 17(7): 732-735.
[13]	姜小敢, 鲁卫华, 金孝岠, 吴敬医, 沈光贵, 王箴. 血必净注射液治疗急性呼吸窘迫综合征临床研究[J]. 中国临床药理学与治疗学, 2012, 17(2): 220-224.
[14]	董一慧, 袁显文, 李鹏. 牛肺表面活性物质与猪肺表面活性物质治疗早产儿呼吸窘迫综合征的临床疗效观察[J]. 中国临床药理学与治疗学, 2012, 17(1): 97-102.
[15]	徐国成, 李志奇. 肺表面活性物质的临床应用进展[J]. 中国临床药理学与治疗学, 2010, 15(7): 832-835.